article thumbnail

STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database

STAT

DNA sequencer manufacturer Illumina has also invested $20 million in the project, which builds on a 2021 investment and partnership from Microsoft, which will provide the cloud infrastructure for the project. Pharmaceutical company Regeneron has invested $119.5 Continue to STAT+ to read the full story…

article thumbnail

STAT+: To mitigate drug shortages, a new study suggests looking at Canada

STAT

Between 2017 and 2021, regulators in the U.S. Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in Canada than in the U.S., a new study found, and the difference was largely attributed to the approach taken by the Canadian government to the problem.

340
340
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

WHO member countries agree on a draft ‘pandemic treaty’ to try to avoid Covid-19 mistakes

STAT

After the world’s  largely disastrous  response to the coronavirus, countries tasked the WHO with overseeing a  pandemic treaty  in 2021; negotiations concluded early Wednesday on an agreement expected to be adopted next month at the U.N. health agency’s annual meeting in Geneva. Read the rest…

261
261
article thumbnail

STAT+: With $40 million, former DeepMind employees launch startup ‘laser-focused’ on AI protein design

STAT

In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem.

235
235
article thumbnail

STAT+: Study shows how UnitedHealth uses coding to rake in extra cash from Medicare Advantage

STAT

Medicare Advantage insurers pulled in an estimated $33 billion in additional payment from the government in 2021 as a result of these extra diagnoses, or codes, that made their members seem sicker, relative to people in the traditional Medicare program.

363
363
article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

Analysis includes innovative medicines with approved indications or indication extensions that were reimbursed since 2021. On average, 58% of branded drugs approved between 2021 and 2024 in Europe have either fully or restricted reimbursement. Patient profiles were counted distinctly.

article thumbnail

STAT+: Pharma’s reputation with patient groups dips again, mostly due to pricing issues

STAT

In 2021, for instance, 59% of companies scored highly, compared with 41% in 2018. The back-to-back declines come after 60% of patient groups believed the industry fared well thanks to the initial response of many companies to quickly develop salves for the Covid-19 pandemic. Continue to STAT+ to read the full story…